NRG-GI002: A phase II clinical trial platform for total neoadjuvant therapy (TNT) in rectal cancer. Background: In metastatic colorectal cancer with deficient DNA mismatch repair (MMR), anti-PD-1 ...
Pathologic complete response (pCR) after neoadjuvant treatment in rectal cancer: Multi-institutional results in Spain. Background: Impact of the preventive oral glutamine intake on the development of ...
Like other types of chemotherapy, FOLFOX involves taking medications that stop cancer cells from replicating. Using a combination of medications helps target cancer cells in different ways. In this ...
FOLFOX is a combination of chemotherapy drugs that can treat colorectal cancer and some other cancers. FOLFOX chemotherapy combines folinic acid, fluorouracil, and oxaliplatin. There are various types ...